Acumen Pharmaceuticals, Inc. (ABOS) vs Minerva Neurosciences, Inc (NERV)
- Acumen Pharmaceuticals, Inc. ABOS 1.69 +1.20%
- Minerva Neurosciences, Inc NERV 2.35 −2.89%
Acumen Pharmaceuticals, Inc. and Minerva Neurosciences, Inc are both Biotechnology companies. Acumen Pharmaceuticals, Inc. and Minerva Neurosciences, Inc are of similar size ($120.8M and $115.6M). Across the 8 metrics below, Acumen Pharmaceuticals, Inc. leads on 4 and Minerva Neurosciences, Inc on 4.
Valuation
Profitability
| Metric | ABOS | NERV | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (120.50%) | 322.05% | (56.36%) |
| Return on assets | (72.97%) | (629.71%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack